Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2009
02/24/2009US7494789 Annealing double stranded RNA polymerase promoter to oligodeoxynucleotide tail by complementary base pairing, ligating 5' end of antisense strand of double stranded RNA polymerase promoter to 3' end of oligodeoxynucleotide tail, and initiating transcription; gene expression analysis; microarrays; kits
02/24/2009US7494784 Identifying modulators of phosphatidylinositol phosphate kinase (PIPKI gamma 661) for use in prevention and treatment of metastatic cancer and nervous system disorders
02/24/2009US7494783 comparing genotypes and/or expression patterns at the acetylcholinesterase, paraoxonase and/or butyrylcholinesterase genes to the genotype and/or expression patterns of the genes in a reference population whose genotype and/or expression pattern of the genes is known
02/24/2009US7494782 Assay for measuring factor viia-antithrombin complexes
02/24/2009US7494781 combining a sample to be tested with a solution, then with reagents comprising luciferin, recombinant luciferase and buffers anddetecting luminescence as an indication for the presence of adenosine triphosphate in said sample; hygiene monitoring
02/24/2009US7494780 Epididymis-specific defensin for evaluating and regulating male fertility
02/24/2009US7494778 Nucleotide sequences specific to Francisella tularensis and methods for the detection of Francisella tularensis
02/24/2009US7494777 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
02/24/2009US7494776 Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands
02/24/2009US7494775 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
02/24/2009US7494774 Assay and compositions for detection of Bacillus anthracis nucleic acid
02/24/2009US7494773 polynucleotides or complements, used as primers and hybridization probes for detecting the presence of the bacterium
02/24/2009US7494772 polynucleotides or complements, used as primers and hybridization probes for detecting the presence of the bacterium
02/24/2009US7494771 A rapid (10 to 15 minutes), simple, flexible and efficient method of nucleic acids extraction for nucleic acid testing assays
02/24/2009US7494770 Mesoscale polynucleotide amplification analysis
02/24/2009US7494769 collecting the aerosol sample on a liquid or solid surface, then adding a heavy atom perturber, activating the sample with a light source, detecting fluorescent signals and comparing the intensities with a respective threshold to selectively detect the biomaterials of interests
02/24/2009US7494768 Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance
02/24/2009US7494767 Assay for TSG101 as inhibitors of HIV production
02/24/2009US7494660 HCV NS3-NS4A protease resistance mutants
02/24/2009US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen
02/24/2009US7494645 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries
02/24/2009US7494555 Microfabricated elastomeric valve and pump systems
02/24/2009CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
02/24/2009CA2322713C Process for the determination of ctp11 and for determining whether a tumor sample has metastatic potential
02/24/2009CA2282746C Prediction of coronary artery disease
02/24/2009CA2272850C Genetic test for equine severe combined immunodeficiency disease
02/24/2009CA2247820C Functionalized nanotubes
02/24/2009CA2224674C Immunoassay and kit with two reagents that are cross-linked if they adhere to an analyte
02/24/2009CA2196920C Process based on the inhibition of phosphatases for detecting and quantifying diarrhoetic shellfish poison
02/24/2009CA2195542C Culture medium for rapid count of coliform bacteria
02/24/2009CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins
02/19/2009WO2009023773A2 Galactokinase inhibitors
02/19/2009WO2009023733A1 Methods and microarrays for detecting enteric viruses
02/19/2009WO2009023725A2 Early detection of cancer by methylated dna in blood
02/19/2009WO2009023547A2 Polymer microfluidic biochip fabrication
02/19/2009WO2009023495A2 Bisubstrate inhibitors of adenylosuccinate synthetase
02/19/2009WO2009023331A2 Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
02/19/2009WO2009023306A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
02/19/2009WO2009023172A2 Predictions of responsiveness to egfr inhibitors
02/19/2009WO2009023145A2 Fam26c polymorphisms and use thereof for the diagnostic and treatment of late onset alzheimer's disease
02/19/2009WO2009023125A1 Neuronostatin and its uses
02/19/2009WO2009023107A1 Biological encoding of large numbers of cells
02/19/2009WO2009023056A2 Systems and methods for detecting toxins in a sample
02/19/2009WO2009023048A2 Markers for metabolic syndrome
02/19/2009WO2009023018A1 Methods for synthesizing a collection of partially indentical polynucleotides
02/19/2009WO2009022939A1 Method for identifying the genotype and subtype of hepatitis c virus on a biological microchip
02/19/2009WO2009022925A1 Processes of producing alcohols
02/19/2009WO2009022683A1 Method of detecting target substance
02/19/2009WO2009022682A1 Method of detecting target substance
02/19/2009WO2009022558A1 Microorganism detection method and microorganism detection kit
02/19/2009WO2009022512A1 Method for obtaining information on formation of double-stranded nucleic acid
02/19/2009WO2009022329A1 Method for detecting microbes
02/19/2009WO2009022152A1 Single molecule spectroscopy using nanoporous membranes
02/19/2009WO2009022129A1 A 3' -based sequencing approach for microarray manufacture
02/19/2009WO2009022125A1 Identification of nucleic acid sequences
02/19/2009WO2009022035A1 Method for the entrapment and immobilisation of oxidoreductase enzymes and use thereof
02/19/2009WO2009021908A2 Disposable enzymatic sensor for liquid samples
02/19/2009WO2009021757A1 Method for synthesizing a cdna in a sample in an enzymatic reaction
02/19/2009WO2009021708A2 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease
02/19/2009WO2009021684A2 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021683A2 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021682A1 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021681A2 Egfr inhibitor treatment marker
02/19/2009WO2009021680A1 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021679A1 Predictive marker for egfr inhibitor treamtent
02/19/2009WO2009021677A1 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021675A1 Predictive marker for egfr inhibitor treatment
02/19/2009WO2009021674A1 Predictive markers for egfr inhibitor treatment
02/19/2009WO2009021673A1 Predictive markers for egfr inhibitors treatment
02/19/2009WO2009021518A1 Method for estimating telomere length
02/19/2009WO2009021338A1 Alternative splicing gene variants in cancer detection
02/19/2009WO2009021325A1 Microrna compositions and methods for the treatment of myelogenous leukemia
02/19/2009WO2009021285A1 Barley with low levels of hordein
02/19/2009WO2009005547A3 Method for electrostatic trapping of molecules in nanopores
02/19/2009WO2009005536A3 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
02/19/2009WO2008156752A3 Vitreous biomarkers and related diagnostics and therapeutics
02/19/2009WO2008154518A3 Materials and methods for modulating protective pathways in epithelial cells
02/19/2009WO2008153804A3 Soybean polymorphisms and methods of genotyping
02/19/2009WO2008152380A3 Lipoprotein surfactant
02/19/2009WO2008151200A3 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
02/19/2009WO2008151089A3 Fluorescent phospholipase a2 indicators
02/19/2009WO2008151023A3 Methods and compositions for multiple displacement amplification of nucleic acids
02/19/2009WO2008147938A3 Wnt5a as an inflammatory disease marker
02/19/2009WO2008137862A3 Methods of using mir34 as a biomarker for tp53 functional status
02/19/2009WO2008132412A3 Method for decontaminating a solution with respect to unwanted nucleic acids
02/19/2009WO2008127789A3 Molecule attachment to nanoparticles
02/19/2009WO2008124847A3 Methods and computer systems for identifying target-specific sequences for use in nanoreporters
02/19/2009WO2008123901A3 Genemap of the human genes associated with endometriosis
02/19/2009WO2008094200A8 Chimeric virus-like particles
02/19/2009WO2008076856A3 Reagents and methods for detecting cyp2d6 polymorphisms
02/19/2009WO2007084585A3 Non-human primate embryonic stem and germ cells: methods of use and methods of making same
02/19/2009WO2006052914A3 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
02/19/2009US20090049565 Methods to Identify Soybean Aphid Resistant Quantitative Trait Loci in Soybean and Compositions Thereof
02/19/2009US20090048435 Oligonucleotide modulation of cell adhesion
02/19/2009US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
02/19/2009US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
02/19/2009US20090048293 Methods for treating bacillus infection
02/19/2009US20090048288 Method of treating stress-mediated depression
02/19/2009US20090048266 Effects of Inhibitors of Fgfr3 on Gene Transcription
02/19/2009US20090048202 Selective inhibitors of translesion dna replication